Replimune’s RP1+nivolumab melanoma BLA faces an FDA decision by Apr 10, 2026. The current cash runway extends to Q1'27. See ...
The Scottish Government's flagship ScotWind project, the Government-run auction of Scotland’s offshore wind licenses, is set to be probed by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results